| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |